TY - JOUR
T1 - Preying on Public Fears and Anxieties in a Pandemic
T2 - Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
AU - Turner, Leigh
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/6/4
Y1 - 2020/6/4
N2 - In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.
AB - In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.
UR - http://www.scopus.com/inward/record.url?scp=85085491393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085491393&partnerID=8YFLogxK
U2 - 10.1016/j.stem.2020.05.003
DO - 10.1016/j.stem.2020.05.003
M3 - Comment/debate
C2 - 32464095
AN - SCOPUS:85085491393
SN - 1934-5909
VL - 26
SP - 806
EP - 810
JO - Cell Stem Cell
JF - Cell Stem Cell
IS - 6
ER -
